日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trained mesenchymal stromal cell-based therapy HXB-319 for treating diffuse alveolar hemorrhage in a pristane-induced murine model.

训练有素的间充质基质细胞疗法 HXB-319 用于治疗普瑞斯坦诱导的小鼠模型中的弥漫性肺泡出血

Bukulmez Hulya, Dennis Adrienne T, Reese-Koc Jane, Sieg Scott F, Clagett Brian, Kleinsorge-Block Sarah, Somoza-Palacios Rodrigo, Singer Nora, Chance Mark, Highland Kristin B, Emancipator Steven N

Interleukin-2 is a potent latency reversal agent in people with treated HIV-1

白细胞介素-2是治疗后HIV-1感染者体内一种有效的潜伏期逆转剂。

Freeman, Michael L; Clagett, Brian M; Leskov, Konstantin; Moisi, Daniela; Yendewa, George A; Sieg, Scott F; Laird, Gregory M; Karn, Jonathan; Jacobson, Jeffrey M; Rodriguez, Benigno; Lederman, Michael M

SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback

SARS-CoV-2单克隆抗体治疗后接种疫苗可改变人类记忆B细胞对表位的识别,提示存在抗体反馈机制。

Bloom, Nathaniel; Ramirez, Sydney I; Cohn, Hallie; Parikh, Urvi M; Heaps, Amy; Sieg, Scott F; Greninger, Alex; Ritz, Justin; Moser, Carlee; Eron, Joseph J; Bajic, Goran; Currier, Judith S; Klekotka, Paul; Wohl, David A; Daar, Eric S; Li, Jonathan; Hughes, Michael D; Chew, Kara W; Smith, Davey M; Crotty, Shane; Coelho, Camila H

Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment

Bio-Plex 和 Meso Scale 多重 SARS-CoV-2 血清学检测的比较研究揭示了单克隆抗体治疗后宿主对 SARS-CoV-2 的抗体反应减弱的证据

Parikh, Urvi M; Heaps, Amy L; Moisi, Daniela; Gordon, Kelley C; Mellors, John W; Choudhary, Manish C; Deo, Rinki; Moser, Carlee; Klekotka, Paul; Landay, Alan L; Currier, Judith S; Eron, Joseph J; Chew, Kara W; Smith, Davey M; Li, Jonathan Z; Sieg, Scott F

Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response

SARS-CoV-2 抗病毒单克隆抗体疗法耐药性对中和抗体反应的影响

Paul, Marc-Kendy; Choudhary, Manish C; Heaps, Amy L; Deo, Rinki; Moisi, Daniela; Gordon, Kelley C; Mellors, John W; Moser, Carlee; Klekotka, Paul; Landay, Alan; Currier, Judith S; Eron, Joseph J; Chew, Kara W; Smith, Davey M; Sieg, Scott F; Parikh, Urvi M; Li, Jonathan Z

Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

抗逆转录病毒疗法在急性或早期 HIV 感染期间对病毒学和免疫学结果的影响:一项多国临床试验的结果

Crowell, Trevor A; Ritz, Justin; Zheng, Lu; Naqvi, Asma; Cyktor, Joshua C; Puleo, Joseph; Clagett, Brian; Lama, Javier R; Kanyama, Cecilia; Little, Susan J; Cohn, Susan E; Riddler, Sharon A; Collier, Ann C; Heath, Sonya L; Tantivitayakul, Pornphen; Grinsztejn, Beatriz; Arduino, Roberto C; Rooney, James F; van Zyl, Gert U; Coombs, Robert W; Fox, Lawrence; Ananworanich, Jintanat; Eron, Joseph J; Sieg, Scott F; Mellors, John W; Daar, Eric S

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection.

使用托珠单抗阻断白细胞介素 6 可降低与接受治疗的人类免疫缺陷病毒感染患者的死亡率相关的炎症指标

Funderburg Nicholas T, Shive Carey L, Chen Zhengyi, Tatsuoka Curtis, Bowman Emily R, Longenecker Chris T, McComsey Grace A, Clagett Brian M, Dorazio Dominic, Freeman Michael L, Sieg Scott F, Moisi Daniela, Anthony Donald D, Jacobson Jeffrey M, Stein Sharon L, Calabrese Leonard H, Landay Alan, Flexner Charles, Crawford Keith W, Capparelli Edmund V, Rodriguez Benigno, Lederman Michael M

SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback

SARS-CoV-2单克隆抗体治疗后接种疫苗会改变人类记忆B细胞的表位识别,提示存在抗体反馈机制。

Coelho, Camila H; Bloom, Nathaniel; Ramirez, Sydney I; Parikh, Urvi M; Heaps, Amy; Sieg, Scott F; Greninger, Alex; Ritz, Justin; Moser, Carlee; Eron, Joseph J; Currier, Judith S; Klekotka, Paul; Wohl, David A; Daar, Eric S; Li, Jonathan; Hughes, Michael D; Chew, Kara W; Smith, Davey M; Crotty, Shane

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial.

在 II 期随机临床试验中,Bamlanivimab 治疗期间出现了 SARS-CoV-2 逃逸突变

Choudhary Manish C, Chew Kara W, Deo Rinki, Flynn James P, Regan James, Crain Charles R, Moser Carlee, Hughes Michael D, Ritz Justin, Ribeiro Ruy M, Ke Ruian, Dragavon Joan A, Javan Arzhang Cyrus, Nirula Ajay, Klekotka Paul, Greninger Alexander L, Fletcher Courtney V, Daar Eric S, Wohl David A, Eron Joseph J, Currier Judith S, Parikh Urvi M, Sieg Scott F, Perelson Alan S, Coombs Robert W, Smith Davey M, Li Jonathan Z

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

他莫昔芬对接受抗逆转录病毒治疗的女性中伏立诺他诱导的人类免疫缺陷病毒表达的影响:艾滋病临床试验组 A5366,MOXIE 试验

Scully, Eileen P; Aga, Evgenia; Tsibris, Athe; Archin, Nancie; Starr, Kate; Ma, Qing; Morse, Gene D; Squires, Kathleen E; Howell, Bonnie J; Wu, Guoxin; Hosey, Lara; Sieg, Scott F; Ehui, Lynsay; Giguel, Francoise; Coxen, Kendyll; Dobrowolski, Curtis; Gandhi, Monica; Deeks, Steve; Chomont, Nicolas; Connick, Elizabeth; Godfrey, Catherine; Karn, Jonathan; Kuritzkes, Daniel R; Bosch, Ronald J; Gandhi, Rajesh T